Kalaris Therapeutics, Inc.
SEC CIK 1754068 · KLRS · last insider filing 2026-06-04
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Patterson Leone D | Director | filed 2025–2026 |
| Akkaraju Srinivas | Director | filed 2025–2026 |
| Adamis Anthony P | Director | filed 2025–2026 |
| Hallal David | Director · Chief Executive Officer | filed 2020–2026 |
| Jovan-Embiricos Morana | Director | filed 2020–2026 |
| Dybbs Michael | Director | filed 2025–2026 |
| Ferrara Napoleone | Director | filed 2025–2026 |
| Oxtoby Andrew | Director · See Remarks | filed 2025–2026 |
| Patel Samir Chandrakant | Director | filed 2025–2025 |
| Sinha Vikas | Director · See Remarks | filed 2020–2025 |
| Brainard Diana | Director · Chief Executive Officer | filed 2020–2024 |
| Bornstein Jeffrey S | Director | filed 2020–2024 |
| Tomasello Shawn | Director | filed 2022–2024 |
| Vera Juan | Director | filed 2020–2024 |
| Brenner Malcolm | Director | filed 2020–2024 |
| Adams Derek N. | Director | filed 2023–2024 |
| Globeways Holdings Ltd | Director | filed 2022–2022 |
| F2 MG Ltd | Director | filed 2022–2022 |
| F2 - TPO Investments LLC | Director | filed 2022–2022 |
| Globeways Holdings II Ltd | Director | filed 2022–2022 |
| F2 Capital I 2020 | Director | filed 2022–2022 |
| F2 MC, LLC | Director | filed 2022–2022 |
| F2 Bioscience AV 2022 LLC | Director | filed 2022–2022 |
| Gadicke Ansbert | Director | filed 2020–2022 |
| Elevatebio, LLC | Director | filed 2020–2022 |
| Wilson John Robert | Director | filed 2020–2021 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Hagen Brett R | Chief Accounting Officer | filed 2020–2026 |
| Feinsod Matthew | Chief Medical Officer | filed 2025–2026 |
| Gall Matthew | Chief Financial Officer | filed 2025–2026 |
| Miller Edward | General Counsel | filed 2020–2025 |
| Piccina Cintia | Chief Commercial Officer | filed 2023–2023 |
| Leen Ann M. | Chief Scientific Officer | filed 2020–2023 |
| VAN Beek Jeroen B | Chief Commercial Officer | filed 2020–2022 |
| Atillasoy Ercem | See Remarks | filed 2020–2022 |
| Melian Agustin | Chief Medical Officer | filed 2020–2021 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.